title: Role of aprotinin in the management of experimental fungal keratitis.
abstract: In an experimentally induced Aspergillus fumigatus fungal keratitis in 20 rabbits, aprotinin, an antiplasmin agent, was studied to find out its role as an adjuvant when given along with other established antifungal agents like natamycin and fluconazole. The 20 rabbits included in this study were randomly divided into four equal treatment groups. Once the ulcer was produced after intrastromal injection of 0.03 ml of A. fumigatus (5.5 x 10(4) spores/ml), different drugs/agents in combination were used in a randomized manner. These were natamycin (5%) + placebo, natamycin + aprotinin (40 IU/ml), fluconazole (0.3%) + placebo and fluconazole + aprotinin. The rabbits were followed up every day to note the signs of healing which included subsidence of corneal infiltration, disappearance of stromal abscess and subsidence of corneal oedema till complete healing. Results showed that the average healing time was 28.2, 28.4, 49.8 and 49.0 days for natamycin + placebo, natamycin + aprotinin, fluconazole + placebo and fluconazole + aprotinin, respectively. It suggests that aprotinin as an adjuvant has no definite role in the management of fungal keratitis. The plasminogen activator-plasmin system which is inhibited by aprotinin may not be the pathway through which filamentous fungi like A. fumigatus cause tissue destruction.
authors.affiliation: Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
authors.forename: N R
authors.initials: NR
authors.lastname: Biswas
authors.forename: H
authors.initials: H
authors.lastname: Das
authors.forename: G
authors.initials: G
authors.lastname: Satpathy
authors.forename: S
authors.initials: S
authors.lastname: Mohanty
authors.forename: A
authors.initials: A
authors.lastname: Panda
mesh_terms: D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy* / Q000382:microbiology; D003315:Cornea / Q000187:drug effects* / Q000382:microbiology; D003320:Corneal Ulcer / Q000188:drug therapy* / Q000382:microbiology; D004359:Drug Therapy, Combination; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D008297:Male; D010866:Natamycin / Q000627:therapeutic use; D011817:Rabbits; D011897:Random Allocation; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000935:Antifungal Agents; D015842:Serine Proteinase Inhibitors; D010866:Natamycin; D015725:Fluconazole; D007611:Aprotinin